@article{1917d12a15df42d2a35c33b119c2c149,
title = "ZCCHC8, the nuclear exosome targeting component, is mutated in familial pulmonary fibrosis and is required for telomerase RNA maturation",
abstract = "Short telomere syndromes manifest as familial idiopathic pulmonary fibrosis; they are the most common premature aging disorders. We used genome-wide linkage to identify heterozygous loss of function of ZCCHC8, a zinc-knuckle containing protein, as a cause of autosomal dominant pulmonary fibrosis. ZCCHC8 associated with TR and was required for telomerase function. In ZCCHC8 knockout cells and in mutation carriers, genomically extended telomerase RNA (TR) accumulated at the expense of mature TR, consistent with a role for ZCCHC8 in mediating TR 3′ end targeting to the nuclear RNA exosome. We generated Zcchc8-null mice and found that heterozygotes, similar to human mutation carriers, had TR insufficiency but an otherwise preserved transcriptome. In contrast, Zcchc8−/− mice developed progressive and fatal neurodevelopmental pathology with features of a ciliopathy. The Zcchc8−/− brain transcriptome was highly dysregulated, showing accumulation and 3′ end misprocessing of other low-abundance RNAs, including those encoding cilia components as well as the intronless replication-dependent histones. Our data identify a novel cause of human short telomere syndromes-familial pulmonary fibrosis and uncover nuclear exosome targeting as an essential 3′ end maturation mechanism that vertebrate TR shares with replication-dependent histones.",
keywords = "Ciliopathy, Lung disease, Nuclear RNA exosome, RNA processing, Telomerase RNA",
author = "Gable, {Dustin L.} and Valeriya Gaysinskaya and Atik, {Christine C.} and {Conover Talbot}, C. and Byunghak Kang and Stanley, {Susan E.} and Pugh, {Elizabeth W.} and Nuria Amat-Codina and Schenk, {Kara M.} and Arcasoy, {Murat O.} and Cory Brayton and Liliana Florea and Mary Armanios",
note = "Funding Information: We are indebted to the proband and family for their generosity, time and participation. We are grateful to Carolyn Applegate for help with the clinical characterization, Emily McNally with the targeted nextgen sequencing and Corina Antonescu for help with the RNA-seq bioinformatics. We appreciate comments on the manuscript from Carol Greider, Jeffry Corden, and Andrew Holland. We appreciate support from the Mouse Transgenic Core, the Genetic Center Resource Facility, especially the Cell Center team, Phenotyping Core, Computational Biology Core, the Oncology Tissue Services Core, and the Center for Infection and Inflammation Imaging Research, all at Johns Hopkins University School of Medicine. This work was supported by National Institutes of Health grants RO1CA225027 and RO1HL119476, an award from the Maryland Cigarette Restitution Fund, the Commonwealth Foundation, the Gary Williams Foundation, and an award from the S&R Foundation Kuno Award (to M.A.). D.L.G. and S.E.S. received support from T32GM007309, and D.L.G. was supported by the Turock Scholars Fund to the Telomere Center at Johns Hopkins. V.G. received support from T32HL007534 and F32HL142207 and L.F. from National Science Foundation ABI-1356078. M.A. acknowledges a gift to the Telomere Center in the name of Mrs. P. Godrej. The Oncology Tissue Services Core was supported by P30CA006973. Publisher Copyright: {\textcopyright} 2019 Gable et al. This article, published in Genes & Development, is available under a Creative Commons License (Attribution-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",
year = "2019",
month = oct,
day = "1",
doi = "10.1101/gad.326785.119",
language = "English (US)",
volume = "33",
pages = "1381--1396",
journal = "Genes and Development",
issn = "0890-9369",
publisher = "Cold Spring Harbor Laboratory Press",
number = "19-20",
}